MoneyWorks4Me

Zim Laboratories informs about issue of duplicate share certificates

23 Sep 2019 Evaluate

As per the Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirement), Regulation 2015, Zim Laboratories has informed that it has received request from the shareholder for issue of Duplicate Share Certificates and accordingly RTA of the Company has marked stop transfer until Duplicate Share Certificates are issued. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..